Avalon GloboCare (ALBT)
Markets KetoAir breath monitors and develops Catch-Up AI video software.
Chief Patrick Flannelly Highlights KetoAir™ Progress in Supporting the Nevada First Responders Holistic Health Reset Program
FREEHOLD, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a technology-innovation company with a strategic focus on developing innovative products and services that serve growing consumer health and technology markets, today provided an update on the Nevada POOL/PACT Holistic Health Reset program launched in collaboration with Saga Health and SpecialtyHealth, Inc. The four-month wellness initiative, which began in August 2025, was designed to support 50 first responders through a comprehensive health optimization program focused on improving metabolic, physical, and behavioral wellness outcomes.
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update
Avalon GloboCare Corp. (NASDAQ: ALBT - Get Free Report) was the target of a significant growth in short interest in February. As of February 13th, there was short interest totaling 133,008 shares, a growth of 31.3% from the January 29th total of 101,273 shares. Approximately 3.5% of the company's stock are short sold. Based on an
Avalon GloboCare (ALBT) Stock Surges On AMD AI News
Shares of Avalon GloboCare Corp (NASDAQ: ALBT) are trading sharply higher Thursday morning after Benzinga exclusively reported that the company joined Advanced Micro Devices Inc's (NASDAQ: AMD) AI Developer Program.
Top 3 Real Estate Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
Head to Head Survey: Avalon GloboCare (NASDAQ:ALBT) versus Fortrea (NASDAQ:FTRE)
Fortrea (NASDAQ: FTRE - Get Free Report) and Avalon GloboCare (NASDAQ: ALBT - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Earnings and Valuation This table compares Fortrea and
S&P 500, Nasdaq wrap up 2025 with impressive annual rises despite year-end dip
4:15pm: That's a wrap on 2025 Stocks wrapped up 2025 with a modest selloff on Wednesday, but the losses did little to overshadow a strong year for the...
Nasdaq, Dow Jones edge lower as Fed minutes show division over December rate cut
4:05pm: Stocks lower on Fed meeting minutes US stocks edged lower following the release of the minutes from the Fed’s latest meeting, which showed officials...
Invinity shares rise as group lands first Endurium Enterprise order
Shares in Invinity Energy Systems PLC (AIM:IES, OTCQX:IESVF, AQSE:IES) rose 4% to 19.18p after the group announced the first commercial order for its...
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Up 41.2% in December
Avalon GloboCare Corp. (NASDAQ: ALBT - Get Free Report) was the target of a large increase in short interest in December. As of December 15th, there was short interest totaling 80,987 shares, an increase of 41.2% from the November 30th total of 57,363 shares. Currently, 2.1% of the shares of the stock are sold short. Based
S&P 500 hits another record as stocks rally into Christmas
1:00pm: Happy holidays! Wall Street closed out a strong session on Tuesday as stocks extended their holiday rally, with the Dow leading the charge. The...
Nike shares rise as Tim Cook purchases $2.95M in stock
Nike Inc (NYSE:NKE, XETRA:NKE) shares moved higher before Wednesday’s opening bell on the news that board member Tim Cook purchased 50,000 shares of the...
ALBT Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Avalon GloboCare Corp. is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Avalon GloboCare Corp. (NASDAQ: ALBT) and YOOV Group Holding Limited is fair to Avalon shareholders. Upon closing of the proposed transaction, Avalon shareholders are expected to own between approximately 2.5% to 2.2% of the common stock of the combined company. Halper Sadeh encourages Avalon shareholders to click here to learn more about their legal rights and options or contact Dan.
Why Is Avalon GloboCare (ALBT) Stock Up 173% Today?
Avalon GloboCare (NASDAQ: ALBT ) stock is up on Wednesday alongside news of a new medical device being launched by Laboratory Services MSO. Laboratory Services MSO is preparing to launch its GeeWhiz External Condom Catheter in the third quarter of 2024.
Why Is Avalon Globocare (ALBT) Stock Down 27% Today?
Avalon Globocare (NASDAQ: ALBT ) stock is down on Tuesday but only after the commercial real estate company's shares underwent a massive rally on Monday on a recent filing. That rally came after the company filed its Form 10-Q with the Securities and Exchange Commission (SEC).
Avalon GloboCare launches KetoAir breathalyzer in the US
Avalon GloboCare Corp (NASDAQ:ALBT) officially unveiled its KetoAir breathalyzer device in the United States at the Hack Your Health by KetoCon 2024 Conference. Specifically engineered for ketogenic health management, KetoAir utilizes nano-sensor-based technology and AI algorithms to not only assess the user's ketosis status but also seamlessly record diet and exercise details into an app.
Avalon GloboCare launches KetoAir breathalyzer in the US
Avalon GloboCare Corp (NASDAQ:ALBT) officially unveiled its KetoAir breathalyzer device in the United States at the Hack Your Health by KetoCon 2024 Conference. Specifically engineered for ketogenic health management, KetoAir utilizes nano-sensor-based technology and AI algorithms to not only assess the user's ketosis status but also seamlessly record diet and exercise details into an app.
Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
FREEHOLD, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today announced the official launch of the KetoAir™ breathalyzer device and related accessories in the U.S. at the Hack Your Health by KetoCon 2024 Conference being held from May 31 to June 2, 2024 in Austin, Texas.
Avalon GloboCare extends exclusive distribution agreement for KetoAir breathalyzer
Avalon GloboCare Corp (NASDAQ:ALBT) announced the extension of its exclusive distribution agreement with Qi Diagnostics for the KetoAir breathalyzer device and related accessories in several key regions, including North America, South America, the United Kingdom and the European Union. Shares of the biotechnology company added 19% at US$0.36 before Thursday's opening bell on the news.
Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
FREEHOLD, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, is pleased to announce the extension of its exclusive distribution agreement with Qi Diagnostics Limited (“Qi Diagnostics”) to distribute the KetoAir™, a breathalyzer device and related accessories, including current and future models, in key regions including North America, South America, the United Kingdom, and the European Union.
Avalon GloboCare engages ChtrBx to develop marketing launch plan for KetoAir
Avalon GloboCare Corp (NASDAQ:ALBT) announced that it has engaged ChtrBx, a marketing and branding company, to develop a marketing launch plan for KetoAir in North America, South America, the United Kingdom (UK) and the European Union (EU). The developer of innovative cell-based technology, cellular therapy and precision diagnostics said KetoAir functions as a companion diagnostic and monitoring device, combined with an artificial intelligence (AI) nutritionist consultation for ketogenic dietary management.